Jai Maruti Medipharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 19-12-2024
- Paid Up Capital ₹ 1.49 M
as on 19-12-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -7.61%
(FY 2020)
- Profit -17.94%
(FY 2020)
- Ebitda -54.19%
(FY 2020)
- Net Worth 8.54%
(FY 2020)
- Total Assets 4.13%
(FY 2020)
About Jai Maruti Medipharma
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.49 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Nigam, Lovelesh Nigam, and Monika Nigam serve as directors at the Company.
- CIN/LLPIN
U85120MP1999PTC013565
- Company No.
013565
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 1999
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Gwalior, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Jai Maruti Medipharma Private Limited offer?
Jai Maruti Medipharma Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Biocides, Fertilizers and Soil Additives, Nitrogen Fertilizers, Gas Cylinders and Accessories, Gas Cylinders.
Who are the key members and board of directors at Jai Maruti Medipharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Nigam  | Director | 04-Jun-1999 | Current |
| Lovelesh Nigam | Director | 28-Nov-2006 | Current |
| Monika Nigam | Director | 15-Dec-2013 | Current |
Financial Performance of Jai Maruti Medipharma.
Jai Maruti Medipharma Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 7.61% decrease. The company also saw a substantial fall in profitability, with a 17.94% decrease in profit. The company's net worth moved up by a moderate rise of 8.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jai Maruti Medipharma?
In 2020, Jai Maruti Medipharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jai Anjaneya Gas Containers Private LimitedActive 27 years 10 monthsAshok Nigam, Lovelesh Nigam and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jai Maruti Medipharma?
Unlock and access historical data on people associated with Jai Maruti Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jai Maruti Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jai Maruti Medipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_LIMITED.webp){kind=small}
